 The Kidney Cancer Association today honored William G. Kalen Jr., presenting him with the Eugene P. Schoenfeld Award at the 11th International Kidney Cancer Symposium held in Chicago. That award is named for the Association's founder, and it honors the significant lifetime contribution of a medical professional to advancing the knowledge of kidney cancer. William G. Kalen Jr. M.D. is professor of medicine at Dana-Farber Cancer Institute and Brigham and Women's Hospital Harvard Medical School. His work has been translated into clinical medicine. His group determined that kidney cancer often involves non-hereditary VHL mutations that have the same effect as hereditary ones. His group hopes to identify genes that complement or cooperate with these mutations to promote kidney cancer. The Kidney Cancer Association was founded in 1990 by a small group of patients, including Dr. Schoenfeld and medical advisors in Chicago. It's a non-profit charity incorporated in the state of Illinois and has been designated as tax exempt under Section 501C3 of the U.S. Internal Revenue Service Code. Reporting from Chicago, I'm Bill Brough.